SELENIUM SULFIDE

Post-LOE

selenium sulfide

Teva

ANDATOPICALLOTION/SHAMPOO

Approved

Sep 1983

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

SELENIUM SULFIDE (selenium sulfide) by Teva. Approved for sunburn if used, decrease the risk of skin cancer, early skin aging caused by the sun. First approved in 1983.

Drug data last refreshed 18h ago

$0.0BPart D

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (3)

sunburn If used decrease the risk of skin cancer early skin aging caused by the sun

Worked on SELENIUM SULFIDE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.